PCSK9 and coronary artery disorder: Moreover, PCSK9 inhibitors suppress the accumulation of the proinflammatory cytokine IL-6 in the plasma of stable coronary artery disease patients with the IL6-74CC genotype and high level of lipoprotein(a) (97).